Welcome to the detailed analysis for medcitynews.com. This domain is officially recognized as MedCity News - Healthcare technology news, life science current events. According to their official web presence, their primary focus is: "Healthcare technology news, life science current events".
"GSK gained rights to a Hutchmed antibody-targeted therapy conjugate, or ATTC. This new type of targeted therapy blocks two cancer-driving proteins and will initially be developed for lung, colorectal, and pancreatic cancers."
"The House VA Committee voted 19-0 to subpoena Oracle Health executives Larry Ellison and Mike Sicilia after learning the VA's EHR contract ballooned from $10 billion to $27 billion — despite Oracle's promise to Congress that it would absorb any costs beyond the original cap."
"Ionis Pharmaceuticals’ zilganersen, brand name Zanvastro, is the first disease-modifying therapy approved for the neurological disorder Alexander disease. While Ionis has experience developing medicines for rare neuroscience indications, Zanvastro will be the first neurology product the company brings to the market without a commercialization partner."
"We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey."
By comparing medcitynews.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to medcitynews.com.
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
As of September 7, 2026, medcitynews.com holds an estimated domain authority score of 31/100 based on our VisitRank tracking algorithms.
You can find the best alternatives and similar sites to medcitynews.com in our explore section, which includes competitors in the News & Media sector.
Common Misspellings & Typo Domains for medcitynews.com: